Topic Archives: Abbvie (ABBV)

Everybody’s got to deviate from the norm.  —Rush John Galsworthy wrote that the beginning and endings of human undertakings are untidy. It was never more so than in the early days of HCV, a mere 20 years ago, when a plague first called “non-A non-B hepatitis” began vexing people, progressively scarring their livers and behaving […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Gumshoe Irregulars. He has agreed to our trading restrictions, he chooses his own topics, and his words and opinions are his own. Enjoy!] OK, admit it….how many of you have seen the campy films of Baltimore director John Waters? The ones starring the […]

“The Greatest Medical Breakthrough in 72 Years… “One Drug to End All Pain — Naturally “A new revolutionary drug called ‘Delta-9’ will send a small group of companies skyrocketing for life-altering gains… starting December 31, 2014. “The last time something like this happened 72 years ago… investors had the opportunity to turn every $1,000 into […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]

[ed note: We feature the musings of our favorite health and medicine writer, Michael Jorrin, a couple times a month, and we’ve taken the liberty of calling him “Doc Gumshoe” (he’s not a doctor). You’ll find no stock picks in his pieces, but hopefully will get plenty of insight into the medical matters he explains […]

Comments

  • SoGiAm

    #Biotech Best turnaround M&A $ARQL 20X $MRK BO in 2yr $ARRY $2s Multiple setbacks ➡️ 20X $PFE BO in 3yr $ECYT...

  • Avatar

    AGN has been a perpetual R&D disappointer. Botox SB ok, but the pipeline is mediocre at best, and stock is not that chea...

  • Avatar

    Travis ---you're right on-----The five he talks about are: ABBV, PFE, JNJ, MRK amd UNH...

  • Avatar

    ABBV has been in a down trend channel since 26 jan 2018...

  • Avatar

    Although this investment letter has done well in the past, since late 2018 it has been the fastest way to lose money I'v...

  • Avatar

    ABBV has been a very good stock over the past 1.5 years. One subscription service said to sell when it fell a month or t...

  • Jay Ram

    Must be Abbvie (ABBV). They want to tender $7.5B worth of their own stock. Sure makes me curious about buying, although ...

  • SoGiAm

    AbbVie's stock climbs after positive late-stage trial results of psoriasis treatment Today 8:12 AM ET (MarketWatch) Sh...

  • SoGiAm

    $ENTA $ABBV MAVIRET™ (glecaprevir/pibrentasvir) Is Now Available in Japan for the Treatment of Chronic Hepatitis C Acr...

  • Avatar

    $AUPH. He made millions in Pharmacyclics (PCYC) which was sold to Abbvie (ABBV). Two or three years ago my first (very...

  • Avatar

    $ABBV $GILD $AMGN - An interesting article from IBD evaluating comparatively three biotech giants "AbbVie Stronger B...

  • Avatar

    $RGLS (long) http://tinyurl.com/z6qeum9 AbbVie ($ABBV) is touting impressive cure rates for its new daily hep C combo...

  • Avatar

    GILD's HEP C scripts latest data. Gilead Sciences: Does Anyone Care About Hep-C Anymore? By Ben Leviso...

  • Avatar

    Got this teaser for a prescription buy to Money Map Press.It was easy to figure out the company.It is Orasure Technologi...

  • Avatar

    I started watching Mike Ward's pitch this afternoon and decided I could dope this out on my own. I spent 6 hours learnin...

  • Avatar

    The following is an excerpt from a piece on GILD: "A group of developers are racing ahead in the clinic with new hep C ...

  • karmaswimswami

    Readers here who might be more comfortable with a blue-chip rather than a speculative pick might really want to take a l...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info